Lipodystrophy: An Overview of Its Management

Authors

  • Kothamasu Pavan Kumar Department ofPharmacy, Nandha College of Pharmacy and Research Institute, Erode, India-638052.
  • V. Amulya Department of Pharmacy, Nandha College of Pharmacy and Research Institute, Koorapalayam Piruvu, Erode-638052, India
  • T. Prabha Department of Pharmacy, Nandha College of Pharmacy and Research Institute, Koorapalayam Piruvu, Erode-638052, India
  • M. Jagadeeswaran
  • S. Sengottuvelu Department of Pharmacy, Nandha College of Pharmacy and Research Institute, Koorapalayam Piruvu, Erode-638052, India
  • T. Sivakumar Department of Pharmacy, Nandha College of Pharmacy and Research Institute, Koorapalayam Piruvu, Erode-638052, India

Keywords:

Lipodystrophy, lipoatrophy, lipohypertrophy, adipose tissue, leptin, laser treatment

Abstract

Lipodystrophy is the acquired or inherited metabolic disorder sophisticated by complete or partial loss of fat in the body. The disorders of lipodystrophy are differentiated by degrees of severity, and by areas or organ systems of the body affected. The pathogenesis remains unestablished, but chiefly it is associated with adipose tissue as well as genetic and other host factors. Genetic and molecular researches help to improve underlying mechanism of the lipodystrophy. Magnetic resonance imaging, dual energy X-ray absorptiometry, computed tomography, ultrasonography and other laboratory tests are helpful to assess the fat content and other related disorders at regular intervals. It is combined with a number of complications mostly diabetes mellitus, dyslipidemia and other metabolic abnormalities. The proper usage of diet, exercise, nutrition and therapeutic usage of growth hormones, anti-diabetic drugs, hyper-lipidemic drugs, changes in HIV medications are helpful in controlling lipodystrophy to an extent. Hormones of adipose tissue, leptin and adiponectin enhance the circulation of peroxisome proliferator activated receptor γ agonists, for therapeutic usage. The novel therapeutic approaches include laser and other potential applications in surgery which guide to therapeutic armamentarium. The new insights from the research and clinical trials could potentially strategize the management of lipodystrophy.


Downloads

Published

2012-06-09

Issue

Vol. 1 No. 1 (2012)

Section

Review Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  • I/We also agree to the authorship of the article in the following order:

Author’s name

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.